Objective To investigate the clinical and genetic features of children with 3-methylcrotonyl-coenzyme A carboxylase deficiency (MCCD). Methods A retrospective analysis was conducted on the clinical manifestations and genetic testing results of six children with MCCD who attended Children's Hospital Affiliated to Zhengzhou University from January 2018 to October 2023. Results Among the six children with MCCD, there were 4 boys and 2 girls, with a mean age of 7 days at the time of attending the hospital and 45 days at the time of confirmed diagnosis. Of all children, one had abnormal urine odor and five had no clinical symptoms. All six children had increases in blood 3-hydroxyisovaleryl carnitine and urinary 3-hydroxyisovaleric acid and 3-methylcrotonoylglycine, and five of them had a reduction in free carnitine. A total of six mutations were identified in the MCCC1 gene, i.e., c.1630del(p.R544Dfs*2), c.269A>G(p.D90G), c.1609T>A(p.F537I), c.639+2T>A, c.761+1G>T, and c.1331G>A(p.R444H), and three mutations were identified in the MCCC2 gene, i.e., c.838G>T(p.D280Y), c.592C>T(p.Q198*,366), and c.1342G>A(p.G448A). Among these mutations, c.269A>G(p.D90G) and c.1609T>A(p.F537I) had not been previously reported in the literature. There was one case of maternal MCCD, and the child carried a heterozygous mutation from her mother. Five children with a reduction in free carnitine were given supplementation of L-carnitine, and free carnitine was restored to the normal level at the last follow-up visit. Conclusions This study identifies two new mutations, c.269A>G(p.D90G) and c.1609T>A(p.F537I), thereby expanding the mutation spectrum of the MCCC1 gene. A combination of blood amino acid and acylcarnitine profiles, urine organic acid analysis, and genetic testing can facilitate early diagnosis and treatment of MCCD, and provide essential data for genetic counseling.
Key words
3-Methylcrotonoyl-coenzyme A carboxylase deficiency /
3-Hydroxyisovalerylcarnitine /
3-Hydroxyisovalerate /
3-Methylcrotonyl-glycine /
MCCC1 gene /
MCCC2 gene /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 Eldjarn L, Jellum E, Stokke O, et al. Beta-hydroxyisovaleric aciduria and beta-methylcrotonylglycinuria: a new inborn error of metabolism[J]. Lancet, 1970, 2(7671): 521-522. PMID: 4194964. DOI: 10.1016/s0140-6736(70)90140-6.
2 李瑞, 许召杰, 赵鼎, 等. MCCC2基因变异致3-甲基巴豆酰辅酶A羧化酶缺乏症患儿的家系分析[J]. 中华医学遗传学杂志, 2021, 38(1): 74-77. PMID: 33423264. DOI: 10.3760/cma.j.cn511374-20200110-00021.
3 顾学范. 临床遗传代谢病[M]. 北京: 人民卫生出版社, 2015: 116-117.
4 贾立云, 王熙, 马翠霞, 等. 石家庄地区3-甲基巴豆酰辅酶A羧化酶缺乏症患病率及MCCC1、MCCC2基因变异分析[J]. 国际生殖健康/计划生育杂志, 2023, 42(2): 111-114. DOI: 10.12280/gjszjk.20220495.
5 戴尊严, 黄靖宇, 魏赛男, 等. 美国临床遗传学检测报告的标准与规范[J]. 中华医学遗传学杂志, 2019, 36(1): 65-91. PMID: 30722095. DOI: 10.3760/cma.j.issn.1003-9406.2019.01.011.
6 Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020, 22(2): 245-257. PMID: 31690835. PMCID: PMC7313390. DOI: 10.1038/s41436-019-0686-8.
7 Frazier DM, Millington DS, McCandless SE, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005[J]. J Inherit Metab Dis, 2006, 29(1): 76-85. PMID: 16601872. DOI: 10.1007/s10545-006-0228-9.
8 谢波波, 罗静思, 雷亚琴, 等. 一种新的复合杂合突变导致3-甲基巴豆酰辅酶A羧化酶缺乏症[J]. 中华医学遗传学杂志, 2016, 33(5): 657-661. PMID: 27577216. DOI: 10.3760/cma.j.issn.1003-9406.2016.05.017.
9 顾学范, 韩连书, 余永国. 中国新生儿遗传代谢病筛查现状及展望[J]. 罕见病研究, 2022, 1(1): 13-19. DOI: 10.12376/j.issn.2097-0501.2022.01.003.
10 马胜举, 赵德华, 马坤, 等. 河南省2013-2019年新生儿遗传代谢病筛查回顾性分析[J]. 检验医学与临床, 2020, 17(14): 1965-1968. DOI: 10.3969/j.issn.1672-9455.2020.14.006.
11 Cho KL, Kim YJ, Yang SH, et al. Maternal 3-methylcrotonyl-coenzyme A carboxylase deficiency with elevated 3-hydroxyisovalerylcarnitine in breast milk[J]. Korean J Pediatr, 2016, 59(Suppl 1): S41-S44. PMID: 28018443. PMCID: PMC5177709. DOI: 10.3345/kjp.2016.59.11.S41.
12 孟卫京, 樊军, 卢文亮, 等. 新生儿筛查中疑诊3-甲基巴豆酰辅酶A羧化酶缺乏症分析[J]. 实用医技杂志, 2019, 26(10): 1228-1231. DOI: 10.19522/j.cnki.1671-5098.2019.10.002.
13 Baumgartner MR, Almashanu S, Suormala T, et al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency[J]. J Clin Invest, 2001, 107(4): 495-504. PMID: 11181649. PMCID: PMC199271. DOI: 10.1172/JCI11948.
14 贾倩芳, 周福军, 崔清洋. 单亲二倍体致3-甲基巴豆酰辅酶A羧化酶缺乏症1例报告并文献复习[J]. 临床儿科杂志, 2021, 39(11): 836-838. DOI: 10.3969/j.issn.1000-3606.2021.11.010.
15 宫丽霏, 叶军, 韩连书, 等. 母源性3-甲基巴豆酰辅酶A羧化酶缺乏症临床及基因突变分析[J]. 中华医学遗传学杂志, 2013, 30(5): 574-578. PMID: 24078573. DOI: 10.3760/cma.j.issn.1003-9406.2013.05.014.
16 Morscher RJ, Grünert SC, Bürer C, et al. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency[J]. Mol Genet Metab, 2012, 105(4): 602-606. PMID: 22264772. DOI: 10.1016/j.ymgme.2011.12.018.
17 Cho SY, Park HD, Lee YW, et al. Mutational spectrum in eight Korean patients with 3-methylcrotonyl-CoA carboxylase deficiency[J]. Clin Genet, 2012, 81(1): 96-98. PMID: 22150417. DOI: 10.1111/j.1399-0004.2011.01704.x.
18 叶军, 宫丽霏, 韩连书, 等. 新生儿筛查疑诊3-甲基巴豆酰辅酶A羧化酶缺乏症患儿的随访及基因分析[J]. 中华儿科杂志, 2014, 52(6): 409-414. PMID: 25190158. DOI: 10.3760/cma.j.issn.0578-1310.2014.06.003.
PDF(1393 KB)
